Francis Chris sold WVE

February 26, 2026 · Form 4 insider transaction

Francis Chris sold 17,900 shares of Wave Life Sciences, Inc. at $15.09 per share, a transaction worth $270.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
17,900
Price
$15.09
Total value
$270.2K
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after61,867
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.; The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR